Dr. Grossman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1441 Eastlake Ave
Los Angeles, CA 90089Phone+1 323-865-0862
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1994 - 1997
- Brigham and Women's HospitalResidency, Internal Medicine, 1991 - 1993
- University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1991
Certifications & Licensure
- CA State Medical License 2021 - 2027
- VA State Medical License 2011 - 2026
- MA State Medical License 1993 - 2012
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 417 citationsCooperation of Stat2 and p300/CBP in signalling induced by interferon-alpha.Shoumo Bhattacharya, Richard Eckner, Steven R. Grossman, Elizabeth Oldread, Zoltan Arany
Nature. 1996-09-26 - 277 citationsThe Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein.Steven R. Grossman, Eric Johannsen, Xiao Tong, Ramana Yalamanchili, Elliott Kieff
Proceedings of the National Academy of Sciences of the United States of America. 1994-08-02 - 203 citationsEpstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1.Eric Johannsen, E. Koh, George Mosialos, Xiao Tong, Elliott Kieff
Journal of Virology. 1995-01-01
Press Mentions
- Dr. Steven Grossman Appointed 1st Chief Cancer Physician of USC Norris Comprehensive Cancer CenterAugust 12th, 2020
- New p53 Gene Discovery Sheds Light on How to Make Cancer Therapies More EffectiveJune 21st, 2019
- Study Uncovers Potential ‘Silver Bullet’ for Preventing and Treating Colon CancerJuly 27th, 2017
Grant Support
- Role Of P300/Cbp And Hhr23 Proteins In P53 RegulationNational Cancer Institute2011–2012
- Role Of P300/Cbp And Hhr23 Proteins In P53 RegulationNational Cancer Institute2010–2011
- Targeting The Arf/Ctbp Axis In Pancreatic CancerNational Cancer Institute2009–2010
- Role Of P300 And Hhr23 Proteins In P53 RegulationNational Cancer Institute2005–2008
- Role Of MDM2, P300, P19ARF In P53 UbiquitinationNational Cancer Institute2003–2005
- P300 And Hhr23 Proteins In P53 RegulationNational Cancer Institute2004
- Role Of MDM2, P300, P19ARF In P53 UbiquitinationNational Cancer Institute2001–2002
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: